Repinotan (BAYx3702)
Modify Date: 2024-01-11 16:33:29
Repinotan (BAYx3702) structure
|
Common Name | Repinotan (BAYx3702) | ||
|---|---|---|---|---|
| CAS Number | 144980-29-0 | Molecular Weight | 400.49100 | |
| Density | 1.284g/cm3 | Boiling Point | 599.5ºC at 760 mmHg | |
| Molecular Formula | C21H24N2O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 316.4ºC | |
Use of Repinotan (BAYx3702)Repinotan (BAY x 3702 free base) is a potent, selective, brain-penetrant and orally active 5-HT1A receptor agonist, with Ki values of 0.19 nM (calf hippocampus), 0.25 nM (rat and human cortex), and 0.59 nM (rat hippocampus). Repinotan has a weak affinity for other related receptors. Repinotan has pronounced neuroprotective effects[1]. |
| Name | 2-[4-[[(2R)-3,4-dihydro-2H-chromen-2-yl]methylamino]butyl]-1,1-dioxo-1,2-benzothiazol-3-one |
|---|---|
| Synonym | More Synonyms |
| Description | Repinotan (BAY x 3702 free base) is a potent, selective, brain-penetrant and orally active 5-HT1A receptor agonist, with Ki values of 0.19 nM (calf hippocampus), 0.25 nM (rat and human cortex), and 0.59 nM (rat hippocampus). Repinotan has a weak affinity for other related receptors. Repinotan has pronounced neuroprotective effects[1]. |
|---|---|
| Related Catalog | |
| Target |
5-HT1A Receptor:0.19 nM (Ki, In calf hippocampus) 5-HT1A Receptor:0.25 nM (Ki, In rat and human cortex) 5-HT1A Receptor:0.59 nM (Ki, In rat hippocampus) 5-HT7 Receptor:6 nM (Ki) |
| In Vitro | Repinotan binds with lower affinity to 5-HT7 (Ki = 6 nM), α1- and α2 adrenergic (Ki = 6 nM and 7 nM, respectively), 5-HT1D (36 nM), dopamine D2 and D4 (48 nM and 91 nM, respectively), σ sites (176 nM) and 5-HT2C (310 nM) receptors[1]. Exposure to repinotan protects rat cortical and hippocampal neurons in cultures from apoptosis induced by 25 nM Staurosporine. After Staurosporine-induced apoptosis, Repinotan, at 50 pM to 1 μM, reduces the release of lactate dehydrogenase, DNA fragmentation, and apoptotic body formation in a concentration-dependent manner[1]. |
| In Vivo | Repinotan (1-100 μg/kg) causes strong, dose-dependent infarct reductions in permanent middle cerebral artery occlusion, transient middle cerebral artery occlusion, and traumatic brain injury paradigms[1]. The half-life of Repinotan in plasma is relatively short (t1/2 = 0.6 h in rat; 0.4 h in rhesus monkeys), and Repinotan is extensively metabolized[1]. |
| References |
| Density | 1.284g/cm3 |
|---|---|
| Boiling Point | 599.5ºC at 760 mmHg |
| Molecular Formula | C21H24N2O4S |
| Molecular Weight | 400.49100 |
| Flash Point | 316.4ºC |
| Exact Mass | 400.14600 |
| PSA | 84.09000 |
| LogP | 4.00430 |
| Vapour Pressure | 2.49E-14mmHg at 25°C |
| Index of Refraction | 1.603 |
| Repinotan [INN] |
| Repinotan |
| Bay x3702 |
| UNII-05PB82Z52L |